Antineutrophil cytoplasmic antibodies (ANCA) are found in the sera of
patients with Wegener's granulomatosis and other systemic necrotising
vasculitides. Antibody levels correlate closely with disease activity
so that follow-up of ANCA titres might be helpful in guiding therapy.
The authors assessed in a cohort of patients with chronic ocular infla
mmatory disease ANCA titres prospectively over a two-year period, by a
n indirect immunofluorescent technique. They found that sera from 10/6
4 patients (15.6%) stained positive for c-ANCA antibodies, and none st
ained for p-ANCA. Six c-ANCA positive patients had one or more clinica
l relapses (range one to three) during this study period. Each relapse
correlated with a rise in ANCA titre. The remaining four patients who
were found to have persistently low titres of c-ANCA had no clinical
relapses. The authors conclude that although c-ANCA is only present in
a small proportion of patients with idiopathic chronic intraocular in
flammatory disease, the ANCA titre may be used to monitor disease acti
vity in this group of patients. Further study to assess the potential
of c-ANCA titres in predicting disease relapse is indicated, which in
the future may minimise the side effects of currently used immunosuppr
essive therapies.